In particular, the finding that acetylcholine-receptor antagonists have an antiproliferative effect on neural stem cells has important implications for the understanding and treatment of Alzheimer ...

Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.

Miwa’s initial work showed that lynx1 was concentrated in the nervous system. Additional studies in collaboration with Ibañez-Tallon showed that lynx-1 altered the function of nicotinic acetylcholine ...

A drug that has recently been approved for the treatment of schizophrenia could one day be prescribed to Alzheimer’s patients ...